Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
RAS and RAF mutation status in the selection of patients for anti-EGFR therapy | Colorectal Cancer
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives - ScienceDirect
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Les biomarqueurs prédictifs dans le cancer colorectal
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Aberrated genetic alterations in the members of EGFR signaling pathways... | Download Scientific Diagram
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed? - Cancer Treatment Reviews
EGFR Signaling in Colorectal Carcinoma
Résultats définitifs de l'essai Bond : Emergence des anticorps monoclonaux anti-EGFR en pratique courante dans le cancer colo-rectal métastatique – CREGG
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
EGFR-mediated signaling pathways and mechanisms of anti-EGFR therapy.... | Download Scientific Diagram
APMG Colon Molecular Pathways
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
Failure is not final: ctDNA-guided rechallenge therapy in colorectal cancer - Annals of Oncology
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Figure 3 from Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar
Anti-EGFR CE/IVD pour IHC - Pathologies hématologiques Clinisciences
